Podcasts for antibody-based pharmaceuticals including Therapeutic antibody/Antibody-drug conjugates/vaccine/CAR-T/Immunotherapy. Creative-Biolabs, the provider, is an outsourced research organization for antibody-drug development.
https://www.creative-biolabs.com/
Gesamtlänge aller Episoden: 2 days 18 hours 44 minutes
- 1
- 2
- 1
- 2
episode 1: Chimeric Antigen Receptor (CAR) Technology
Creative Biolabs has archived professional academic reports and the latest scientific progress of immune cell-based therapies, by making it into a podcast column. Today, we are going to share some basic knowledge about Chimeric Antigen Receptor or CA...
episode 2: Virus-Based Gene Delivery System for CAR T Cell Engineering
Creative Biolabs has archived professional academic reports and the latest scientific progress of immune cell-based therapies, by making it into a podcast column. Here is a brief introduction about lentiviral vector gene delivery system and its appli...
episode 3: Ep.1 Multiple Aspects of Chimeric Antigen Receptor T Cells
This episode focuses on some basic aspects of CAR-T cell therapy, such as types of CARs, co-stimulatory domains, gene transfer strategies, and current challenges.
episode 4: Ep.2 CAR-T Cells for Leukemias in Children
Leukemia remains the leading cause of death from childhood cancer. This episode focuses on how CAR-T cell therapy brings hope to childhood leukemia patients.
episode 5: Ep.3 CAR-T Cells for Leukemias in Adults
This episode focuses on the clinical outcomes in adult leukemia patients treated with CAR-T cells, current challenges limiting the efficacy, and future research directions.
episode 6: Ep.4 Multiple Aspects of T Cell Receptors-Gene-Modified T Cells for Cancer
This episode focuses on various aspects of TCR-engineered T-cell therapy, such as risks, clinical trials, and comparison between TCR-engineered T cells and CAR-T cells.
episode 7: Ep.5 Advances In the Generation of Cytomegalovirus-Specific T Cells
This episode focuses on obstacles and corresponding strategies in allogeneic hematopoietic cell transplantation, and the progress in generating cytomegalovirus-specific T cells.
episode 8: Ep.6 Advances In the Generation of Epstein-Barr Virus-Specific and Multi-Virus-Specific T cells
This episode focuses on the introduction to Epstein-Barr virus and Epstein-Barr virus-specific T cells, as well as advances in the development of multi-virus-specific T cells.
episode 9: Ep.7 Advances in Broadening the Repertoire of Available Donor Sources
This episode focuses on advances in broadening the repertoire of available donor sources, including the generation of virus-specific T cells from virus-naïve individuals and the use of third-party donors.
episode 10: Vaccine for Cancer Immunotherapy
Cancer vaccines are designed to stimulate anti-tumor immunity through active immunization with tumor antigens and has long been envisioned as a key tool of effective cancer immunotherapy. Today we will go through the history, formulations, mechanisms...
- 1
- 2
- 1
- 2